MOL 0275Alternative Names: MOL 027-5
Latest Information Update: 28 Nov 1997
At a glance
- Originator Molecumetics
- Class Antivirals
- Mechanism of Action HIV envelope protein gp120 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 28 Nov 1997 Discontinued-Preclinical for HIV-1 infections in USA (Unknown route)
- 10 Oct 1995 Preclinical development for HIV-1 infections in USA (Unknown route)
- 29 Sep 1995 New profile